Source comparison
CJC-1295 no DAC vs CJC-1295 no DAC & Ipamorelin: Research Protocol Comparison
The table below summarizes the key differences between monotherapy and combination therapy across research-relevant parameters. These distinctions guide protocol selection based on study objectives. Receptor Pathway GHRH receptor agonist; extends endogenous GH
This comparison does not assign a generated winner or score.
- The table below summarizes the key differences between monotherapy and combination therapy across research-relevant parameters. These distinctions guide protocol selection based on study objectives.
- Receptor Pathway
- GHRH receptor agonist; extends endogenous GHRH half-life
- Dual-pathway: GHRH receptor (CJC) + ghrelin receptor (Ipamorelin)
- Combination activates complementary pathways, avoiding receptor saturation
- GH Pulse Amplitude
- Moderate increase (2–3× baseline)
- High increase (3–5× baseline)
- Combination produces significantly greater peak GH levels
- GH Pulse Frequency
- No change from baseline pulse frequency
- Increased frequency; mimics youthful pulsatile pattern
- Ipamorelin independently triggers additional pulses
- IGF-1 Elevation
- 30–40% above baseline, sustained 3–4 hours
- 50–70% above baseline, sustained 6–8 hours
- Longer IGF-1 exposure window with combination therapy
- Typical Dosing
- 100 mcg, 1–3× daily
- 100 mcg CJC + 200 mcg Ipamorelin, 1–2× daily
- Combination requires fewer daily doses for equivalent AUC
- Side Effect Profile
- Minimal; transient facial flushing or injection site irritation
- Minimal; Ipamorelin's selectivity avoids cortisol/prolactin elevation
- Both protocols well-tolerated; combination does not increase adverse events
- Body Composition Impact (12-week protocols)
- Moderate lean mass gain; modest fat loss
- Greater lean mass accretion and fat reduction
- Combination consistently outperforms in body composition endpoints
- Best Research Application
- GH deficiency models, baseline normalization studies
- Anabolic signaling, tissue repair, metabolic optimization
- Use combination when research goal involves replicating youthful GH patterns